AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Pretax margin (%)

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.22T
P/E ratio
16.7x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 20251.6+4.91%
Mar 31, 20241.6-82.14%
Mar 31, 20238.7-27.99%
Mar 31, 202212.1+4.07%
Mar 31, 202111.6-38.34%
Mar 31, 202018.9-1.04%
Mar 31, 201919.1+13.62%
Mar 31, 201816.8-21.92%
Mar 31, 201721.5+12.65%
Mar 31, 201619.1+25.39%
Mar 31, 201515.2+3.69%
Mar 31, 201414.7-6.15%
Mar 31, 201315.6+12.13%
Mar 31, 201213.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)